Review Article
Takotsubo Cardiomyopathy and Autoimmune Disorders: A Systematic Scoping Review of Published Cases
Table 2
Background diseases of 155 patients with Takotsubo cardiomyopathy associated with an autoimmune disease, n (%).
| | | Male (n = 25) | Female (n = 130) | Total (n = 155) |
| | Past medical history | | Not reported | 13 (52.0%) | 41 (31.5%) | 55 (35.0%) | | Reported | 12 (48.0%) | 89 (68.5%) | 102 (65.0%) | | Overall | | CVD | 7 (28.0%) | 37 (28.5%) | 44 (28.0%) | | AI | 5 (20.0%) | 75 (57.7%) | 81 (51.5%) | | Other diseases | 7 (28.0%) | 52 (40%) | 60 (38.2%) | | Case by case | | Isolated CVD | 3 (12.0%) | 4 (3.1%) | 7 (4.4%) | | Isolated AI | 1 (4.0%) | 23 (17.7%) | 24 (15.2%) | | Other diseases (only) | 3 (12.0%) | 9 (6.9%) | 12 (7.6%) | | CVD and AI | 1 (4.0%) | 10 (7.7%) | 11 (7.0%) | | CVD and other diseases | 1 (4.0%) | 1 (0.8%) | 2 (1.2%) | | AI and other diseases | 1 (4.0%) | 20 (15.4%) | 22 (14.0%) | | CVD and AI and other diseases | 2 (8.0%) | 22 (16.9%) | 24 (15.2%) |
|
|
CVD: cardiovascular disease, AI: autoimmune diseases.
|
